Stock listing
NASDAQ:MYSZ MySize, Inc. Stock
Home listing (NASDAQ) of MySize, Inc.
Follow MySize, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:MYSZ
$0.87 USD +0.16 (+22.5%)
Close on Nov 20, 2026
- Day range
- $0.693 – $0.96 USDNov 20, 2026
- Volume
- 368,263 sharesNov 20, 2026
- Market cap
- $1.03M USDAt the close on Nov 20, 2026 · price × 1.18M shares outstanding
- 52-week range
- $0.616 – $9.76 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $1.26M USDMedian day 50,059 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MYSZ · Home | $0.87 USD | +0.16 (+22.5%) | 368,263 | $0.822 | $0.96 | $0.693 | $0.71 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:MYSZ · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.87 | +0.16 | +22.5% | $0.822 | $0.96 | $0.693 | 368,263 | |
| $0.71 | +0.036 | +5.3% | $0.65 | $0.767 | $0.647 | 1,232,205 | |
| $0.674 | +0.012 | +1.8% | $0.681 | $0.687 | $0.65 | 16,071 | |
| $0.662 | -0.016 | -2.4% | $0.66 | $0.68 | $0.616 | 27,025 | |
| $0.678 | -0.001 | -0.2% | $0.659 | $0.715 | $0.65 | 49,989 | |
| $0.68 | -0.016 | -2.3% | $0.69 | $0.711 | $0.659 | 18,844 | |
| $0.696 | -0.057 | -7.5% | $0.71 | $0.71 | $0.655 | 61,873 | |
| $0.752 | +0.062 | +9.0% | $0.70 | $0.77 | $0.68 | 59,508 | |
| $0.69 | -0.042 | -5.7% | $0.73 | $0.73 | $0.68 | 30,839 | |
| $0.732 | -0.068 | -8.5% | $0.79 | $0.79 | $0.726 | 21,475 | |
| $0.80 | -0.007 | -0.9% | $0.77 | $0.801 | $0.76 | 9,034 | |
| $0.808 | -0.048 | -5.6% | $0.83 | $0.856 | $0.736 | 26,539 | |
| $0.856 | -0.014 | -1.6% | $0.837 | $0.86 | $0.81 | 46,069 | |
| $0.87 | -0.08 | -8.4% | $0.93 | $0.93 | $0.85 | 49,790 | |
| $0.95 | -0.04 | -4.1% | $0.98 | $0.98 | $0.94 | 35,505 | |
| $0.99 | -0.015 | -1.5% | $1.01 | $1.04 | $0.97 | 28,905 | |
| $1.005 | -0.015 | -1.5% | $0.994 | $1.03 | $0.975 | 40,329 | |
| $1.02 | -0.02 | -1.9% | $0.982 | $1.055 | $0.965 | 132,469 | |
| $1.04 | +0.10 | +10.6% | $0.94 | $1.10 | $0.92 | 499,266 | |
| $0.94 | -0.10 | -9.6% | $1.02 | $1.04 | $0.931 | 79,387 | |
| $1.04 | 0.00 | 0.0% | $1.03 | $1.09 | $1.01 | 61,039 | |
| $1.04 | -0.05 | -4.6% | $1.07 | $1.09 | $1.00 | 81,675 | |
| $1.09 | +0.06 | +5.8% | $1.22 | $1.23 | $1.03 | 375,366 | |
| $1.03 | -0.09 | -8.0% | $1.12 | $1.15 | $1.02 | 43,056 | |
| $1.12 | -0.02 | -1.8% | $1.16 | $1.16 | $1.03 | 87,830 | |
| $1.14 | -0.05 | -4.2% | $1.183 | $1.28 | $1.11 | 63,073 | |
| $1.19 | +0.03 | +2.6% | $1.18 | $1.25 | $1.14 | 50,128 | |
| $1.16 | -0.115 | -9.0% | $1.24 | $1.32 | $1.16 | 83,103 | |
| $1.275 | +0.045 | +3.7% | $1.21 | $1.50 | $1.20 | 278,724 | |
| $1.23 | -0.02 | -1.6% | $1.27 | $1.30 | $1.19 | 65,968 | |
| $1.25 | -0.10 | -7.4% | $1.44 | $1.49 | $1.25 | 45,759 | |
| $1.35 | -0.12 | -8.2% | $1.485 | $1.50 | $1.31 | 134,686 | |
| $1.47 | -0.10 | -6.4% | $1.54 | $1.61 | $1.43 | 83,181 | |
| $1.57 | -0.01 | -0.6% | $1.59 | $1.62 | $1.55 | 19,002 | |
| $1.58 | -0.03 | -1.9% | $1.645 | $1.68 | $1.55 | 8,752 | |
| $1.61 | +0.01 | +0.6% | $1.649 | $1.649 | $1.57 | 16,746 | |
| $1.60 | -0.05 | -3.0% | $1.60 | $1.65 | $1.59 | 16,013 | |
| $1.65 | -0.04 | -2.4% | $1.70 | $1.70 | $1.61 | 35,094 | |
| $1.69 | +0.06 | +3.7% | $1.60 | $1.71 | $1.595 | 38,843 | |
| $1.63 | -0.09 | -5.2% | $1.68 | $1.722 | $1.60 | 51,113 | |
| $1.72 | -0.06 | -3.4% | $1.72 | $1.77 | $1.67 | 63,138 | |
| $1.78 | -0.10 | -5.3% | $1.87 | $1.87 | $1.75 | 91,821 | |
| $1.88 | +0.20 | +11.9% | $1.715 | $1.92 | $1.63 | 524,624 | |
| $1.68 | +0.05 | +3.1% | $1.78 | $1.78 | $1.60 | 139,755 | |
| $1.63 | -0.12 | -6.9% | $1.76 | $1.77 | $1.60 | 72,468 | |
| $1.75 | -0.15 | -7.9% | $1.85 | $2.093 | $1.75 | 108,864 | |
| $1.90 | -0.07 | -3.6% | $1.77 | $1.989 | $1.749 | 175,488 | |
| $1.97 | -0.35 | -15.1% | $1.88 | $2.13 | $1.73 | 2,609,511 | |
| $2.32 | +0.66 | +39.8% | $2.38 | $2.60 | $1.84 | 28,827,910 | |
| $1.66 | -0.07 | -4.0% | $1.71 | $1.939 | $1.66 | 1,926,878 | |
| $1.73 | -0.21 | -10.8% | $1.90 | $1.939 | $1.71 | 40,610 | |
| $1.94 | -0.07 | -3.5% | $1.99 | $2.01 | $1.90 | 21,208 | |
| $2.01 | -0.13 | -6.1% | $2.14 | $2.141 | $2.00 | 27,163 | |
| $2.14 | -0.12 | -5.3% | $2.26 | $2.36 | $2.14 | 20,355 | |
| $2.26 | -0.11 | -4.6% | $2.35 | $2.35 | $2.26 | 2,828 | |
| $2.37 | +0.07 | +3.0% | $2.33 | $2.37 | $2.27 | 22,344 | |
| $2.30 | -0.06 | -2.5% | $2.40 | $2.41 | $2.241 | 25,683 | |
| $2.36 | -0.16 | -6.3% | $2.56 | $2.56 | $2.10 | 184,776 | |
| $2.52 | -0.08 | -3.1% | $2.60 | $2.65 | $2.51 | 14,302 | |
| $2.60 | 0.00 | 0.0% | $2.54 | $2.68 | $2.488 | 44,736 | |
| $2.60 | +0.06 | +2.4% | $2.51 | $2.61 | $2.505 | 22,607 | |
| $2.54 | -0.04 | -1.6% | $2.59 | $2.64 | $2.53 | 20,317 | |
| $2.58 | -0.02 | -0.8% | $2.55 | $2.73 | $2.53 | 56,879 | |
| $2.60 | +0.09 | +3.6% | $2.49 | $2.65 | $2.47 | 57,400 | |
| $2.51 | +0.09 | +3.7% | $2.48 | $2.60 | $2.44 | 47,942 | |
| $2.42 | -0.04 | -1.6% | $2.44 | $2.72 | $2.346 | 81,134 |
Splits
4 splits since 2019 · NASDAQ:MYSZ · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-8 | Consolidation | |
| 1-for-8 | Consolidation | |
| 1-for-25 | Consolidation | |
| 1-for-15 | Consolidation |
- Ticker
- NASDAQ:MYSZ
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news
MySize Reports Third Quarter and Nine-Month 2026 Financial Results; Nine-Month Revenue Up 21%, Advances Operational Restructuring and Strategic Diversification
Nov 20, 2026
Closed $0.87 (+22.5%) on Nov 20, 2026
MySize Announces $2.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Sep 15, 2026
Closed $1.97 (-15.1%) on Sep 16, 2026
MySize Announces Acquisition-Led Strategy Focused on Defense Technology
Sep 14, 2026
Closed $1.66 (-4.0%) on Sep 14, 2026
MySize's Naiz Fit Surpasses 500 Million Size Recommendations as AI Fashion Platform Expands Into Virtual Try-On
Aug 18, 2026
Closed $2.32 (-24.7%) on Aug 18, 2026
MySize Reports 53% Year-Over-Year Revenue Growth in Second Quarter 2026 as Integrated Fashion Platform Continues to Scale
Aug 14, 2026
Closed $2.97 (-12.1%) on Aug 14, 2026
MySize Announces Reverse Stock Split
Aug 11, 2026
Closed $3.05 (-1.0%) on Aug 11, 2026
MySize Reports 62% Revenue Growth in First Quarter 2026 as Integrated AI Fashion Platform Continues Expansion
May 15, 2026
Closed $4.16 (-1.9%) on May 15, 2026
MySize, Inc. to Present at the Market Movers Investor Summit
May 4, 2026
Closed $4.96 (-0.2%) on May 4, 2026
MySize Subsidiary Signs LOI to Acquire EyeFitU Assets, Expanding AI Sizing Platform and Global Customer Base
Mar 25, 2026
Closed $4.95 (+3.5%) on Mar 26, 2026
MySize Subsidiary Signs Non-Binding LOI to Acquire Selected Assets of EyeFitU to Expand AI Sizing Platform and Global Customer Base
Mar 23, 2026
Closed $4.64 (-4.9%) on Mar 23, 2026
MySize, Inc. on 6ix
- News releases
- 17 in the last 12 months · 145 in all · newest Nov 20, 2026 · oldest 2019
- Decks
- 16 decks · latest Oct 27, 2025
Where MySize, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MYSZ · Home listing · This page | NASDAQ | United States | USD |
| gettex:2YJ0 | gettex | Germany | EUR |
| BOATS:MYSZ | BOATS | United States | USD |
| Frankfurt:2YJ0 | Frankfurt | Germany | EUR |
| Munich:2YJ0 | Munich | Germany | EUR |
Cash and shares
Sep 30, 2025 · My Size — Investor Presentation (October 2025)
- Cash
- $4.5 million
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- −$369,544 USD
- P/E
- Loss
- EV/sales
- −0.0×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.3×
- Gross margin
- 27.8%
- Operating margin
- −71.0%
- Net margin
- −75.6%
- Debt to equity
- 0.3×
- Beta vs S&P 500
- 0.38
Forecasts
Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.
- Price target
- 3.00 USD · Analysts' mean
- EPS, year to Dec 2026
- -2.70 · 1 analyst
Team and board
| Officer | Role |
|---|---|
| Ronen Luzon | Founder & CEO |
| Oren Elmaliah | CHIEF FINANCIAL OFFICER |
| Billy Pardo | CHIEF PRODUCT OFFICER |
| Borja Cembrero Saralegui | Chief Growth Officer |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 19, 2026 | +29.1% |
| Q2 2026 | Aug 13, 2026 | |
| Q1 2026 | Apr 15, 2026 · After close | +4.5% |
| Q4 2025 | Feb 25, 2026 | +0.7% |
| Q3 2025 | Nov 14, 2025 | −9.0% |
| Q2 2025 | Aug 14, 2025 | −8.5% |
| Q1 2025 | May 15, 2025 | −3.3% |
| Q4 2024 | Mar 27, 2025 · After close | +42.1% |
| Q3 2024 | Nov 14, 2024 · After close | −11.8% |
| Q2 2024 | Aug 12, 2024 · After close | −6.9% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Apr 1, 2024 · After close | +3.5% |
| Q4 2023 | Feb 28, 2024 | −4.4% |
| Q3 2023 | Nov 14, 2023 · After close | +3.9% |
| Q2 2023 | Aug 14, 2023 · After close | 0.0% |
| Q1 2023 | Apr 14, 2023 · After close | −11.7% |
| Q4 2022 | Mar 29, 2023 | +1.2% |
| Q3 2022 | Nov 15, 2022 | −9.4% |
| Q2 2022 | Aug 16, 2022 | +16.8% |
| Q1 2022 | May 13, 2022 | +8.7% |
| Q4 2021 | Mar 18, 2022 · Before open | +7.5% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (October 2025) | Investor deck | 19 slides | Oct 27, 2025 |
| Investor Presentation (October 2025) | Investor deck | 19 slides | Oct 22, 2025 |
| Investor Presentation (May 2025) | Investor deck | 19 slides | May 2025 |
| Investor Presentation (December 2023) | Investor deck | 16 slides | December 2023 |
| Investor Presentation (April 2023) | Investor deck | 18 slides | Apr 24, 2023 |
| Investor Presentation (November 2021) | Investor deck | 23 slides | November 2021 |
| Investor Presentation (September 2020) | Investor deck | 29 slides | September 2020 |
| Investor Presentation (April 2020) | Investor deck | 32 slides | Apr 22, 2020 |
| Investor Presentation (February 2019) | Investor deck | 42 slides | Feb 8, 2019 |
| Investor Presentation (December 2018) | Investor deck | 42 slides | Dec 6, 2018 |
All 16 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2018) | Investor deck | 40 slides | Aug 1, 2018 |
| Investor Presentation (April 2018) | Investor deck | 32 slides | April 2018 |
| Conference Presentation (March 2018) | Conference | 33 slides | Mar 16, 2018 |
| Investor Presentation (September 2017) | Investor deck | 45 slides | Sep 11, 2017 |
| Investor Presentation (October 2016) | Investor deck | 35 slides | Oct 31, 2016 |
| Investor Presentation (2016) | Investor deck | 35 slides | 2016 |
Financings
| Raise | Date |
|---|---|
| Private placement of shares of common stock (or pre-funded warrants) with Series C and Series D warrants Announced: about US$2.5M · US$1.91 a share · Warrants at US$1.66 · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: General corporate purposes, including working capital | Sep 16, 2026 |
| Warrant exercise of outstanding warrants Closed: US$3M in the latest tranche Use of proceeds: Expand Orgad's capabilities: operational efficiencies, inventory growth and reach across e-commerce platforms | Jan 3, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.36M | 8.26M | 7.00M | 4.46M | 131.0K | 142.0K | 63.0K | 0 | 0 | 0 |
| Cost of revenue | 6.36M | 4.93M | 4.26M | 3.83M | 251.0K | 2.00K | 21.0K | 29.8K | 31.1K | 23.9K |
| Gross profit | 3.00M | 3.32M | 2.73M | 634.0K | 131.0K | 140.0K | 42.0K | -29.8K | -31.1K | -23.9K |
| Research and development | 597.0K | 429.0K | 974.0K | 1.70M | 4.25M | 1.52M | 1.52M | 1.10M | 845.0K | 727.0K |
| Selling, general and administrative | 4.79M | 3.99M | 5.19M | 5.19M | 5.62M | 2.57M | 3.78M | 3.40M | 4.52M | 1.73M |
| Operating income | -5.74M | -3.94M | -6.74M | -8.11M | -10.6M | -6.15M | -5.99M | -5.17M | -5.61M | -2.59M |
| Depreciation and amortization | 342.0K | 314.0K | 329.0K | 193.0K | 42.0K | 82.0K | 30.0K | 31.0K | 30.0K | 24.0K |
| EBITDA | -5.40M | -3.63M | -6.41M | -7.92M | -10.5M | -6.06M | -5.96M | -5.14M | -5.58M | -2.56M |
| Interest expense | 112.0K | 78.0K | 56.0K | 236.0K | 9.00K | 7.00K | 3.00K | 192.0K | 532.0K | 528.0K |
| Income before tax | -5.85M | -4.00M | -6.71M | -8.35M | -10.5M | 6.16M | -5.50M | -4.13M | -1.42M | -2.62M |
| Income tax | -333.0K | -36.0K | 288.0K | 11.0K | -93.9K | -602.0K | 532.0K | 528.0K | ||
| Net income | -5.85M | -4.00M | -6.38M | -8.31M | -10.5M | -6.16M | -5.50M | -5.97M | -5.40M | -4.33M |
| Earnings per share, basic | -1.87 | -4.39 | -20.40 | -7.47 | -17.75 | -1.11 | -2.75 | -3.03 | -0.30 | -0.27 |
| Earnings per share, diluted | -1.87 | -4.39 | -20.40 | -7.47 | -0.71 | -1.11 | -3.12 | -3.03 | -0.30 | -0.27 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.30M | 4.88M | 2.19M | 2.10M | 10.7M | 1.69M | 1.20M | 5.14M | 1.80M | 34.0K |
| Short-term investments | 22.0K | 59.0K | 0 | 1.21M | 70.0K | 0 | ||||
| Receivables | 1.21M | 278.0K | 615.0K | 1.94M | 40.0K | 28.0K | 38.0K | 88.0K | 326.0K | 1.38M |
| Inventory | 3.03M | 2.80M | 2.88M | 997.0K | -150.0K | 59.0K | -53.0K | 0 | 0 | |
| Current assets | 7.74M | 9.07M | 6.63M | 6.06M | 11.6M | 2.47M | 1.82M | 6.84M | 2.25M | 1.50M |
| Property, plant and equipment | 110.0K | 67.0K | 121.0K | 140.0K | 112.0K | 128.0K | 141.0K | 71.0K | 67.0K | 74.0K |
| Goodwill | 640.0K | 133.0K | 758.0K | 1.40M | 0 | 0 | 0 | |||
| Total assets | 10.2M | 10.1M | 8.99M | 9.73M | 12.6M | 3.57M | 2.96M | 7.12M | 2.42M | 2.15M |
| Accounts payable | 2.22M | 2.08M | 2.15M | 2.49M | 453.0K | 400.0K | 378.0K | 276.0K | 336.0K | 316.0K |
| Current liabilities | 4.13M | 3.00M | 3.88M | 4.18M | 1.23M | 911.0K | 1.25M | 1.82M | 3.57M | 625.0K |
| Long-term debt | 831.0K | 146.0K | 249.0K | 376.0K | 0 | 0 | ||||
| Total debt | 925.0K | 253.0K | 407.0K | 531.0K | 611.0K | 708.0K | 761.0K | 558.0K | ||
| Total liabilities | 5.05M | 3.15M | 4.26M | 5.19M | 1.70M | 1.49M | 1.91M | 1.82M | 3.57M | 625.0K |
| Shareholders' equity | 5.16M | 6.91M | 4.74M | 4.54M | 10.9M | 2.08M | 1.05M | 5.29M | -1.15M | 1.52M |
| Shares outstanding | 580.0K | 2.04M | 452.7K | 1.46M | 959.3K | 7.23M | 2.09M | 1.99M | 22.2M | 17.4M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -5.14M | -3.09M | -6.11M | -7.29M | -7.30M | -5.68M | -5.42M | -3.60M | -4.14M | -2.16M |
| Capital spending | -16.0K | -7.00K | -7.00K | -27.0K | -23.0K | -16.0K | -103.0K | -40.0K | -16.0K | -36.0K |
| Free cash flow | -5.16M | -3.10M | -6.11M | -7.32M | -7.32M | -5.70M | -5.52M | -3.64M | -4.16M | -2.19M |
| Cash from investing | -196.0K | 53.0K | -7.00K | -993.0K | 161.0K | -211.0K | 1.07M | -1.42M | -16.0K | -36.0K |
| Cash from financing | 3.00M | 5.59M | 6.13M | -67.0K | 16.3M | 6.09M | 266.0K | 9.04M | 5.93M | 1.31M |
| Dividends paid | 0 | 0 | ||||||||
| Share buybacks | 3.94M | 0 | 0 | |||||||
| Change in cash | -2.32M | 2.62M | -99.0K | -8.58M | 9.17M | 308.0K | -3.76M | 3.36M | 1.78M | -885.0K |
Cap table
Built by 6ix from MySize, Inc.’s releases · as of Sep 16, 2026
- Common shares
- 1,181,256
- Fully diluted
- 1,181,256
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 1,181,256 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 1,181,256 |
| Aug 11, 2026 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Roy Golan Other companies: NeuroSense Therapeutics Ltd. (Director · Since at least Mar 18, 2026); Ayala Pharmaceuticals Inc (Chief Financial Officer · Oct 18, 2023 – Oct 18, 2023 · Past) | Director · Since at least Mar 6, 2025 |
| Oren Elmaliah Other companies: Nasus Pharma Ltd. (Interim CFO · Since at least Sep 19, 2026) | CHIEF FINANCIAL OFFICER · Since at least May 1, 2017 |
| Billy Pardo | CPO & COO · Since at least Sep 29, 2022 |
| Borja Cembrero Saralegui | Chief Growth Officer · Since at least May 30, 2025 |
| Eliyahu Walles | Director · Nov 2, 2016 – Jul 24, 2017 · Past |
| Ezequiel Javier Brandwain | Chief Commercial Officer · Sep 29, 2022 – Sep 29, 2022 · Past |
| Ilia Turchinsky | Chief Technology Officer · Apr 15, 2019 – Sep 29, 2022 · Past |
| Moshe Zvi Gidansky | Director · Nov 7, 2016 – Nov 7, 2016 · Past |
| Oded Shoshan | Chief Technical Officer · Dec 29, 2016 – Jul 24, 2017 · Past |
| Ronen Luzon | Founder & CEO · Since at least Sep 14, 2026 |
All 12 people
| Person | Seat |
|---|---|
| Saralegui Borja Cembrero | Chief Growth Officer · Since at least May 21, 2025 |
| Shoshana Herman | Director · Dec 21, 2016 – Dec 21, 2016 · Past |
Log in to ask 6ix AI your own questions about MySize, Inc.